Back to search

Spain· ES:62699

OMNISCAN 0,5 mmol/ml SOLUCION INYECTABLE

A medicinal product containing gadodiamida, registered in Spain by Ge Healthcare Bio-Sciences, S.A.U..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedOMNISCAN 0,5 mmol/ml SOLUCION INYECTA…ATC—REGISTER NO.ES:62699PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
gadodiamida
Manufacturer
Ge Healthcare Bio-Sciences, S.A.U.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gadodiamida in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gadodiamida products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Omniscan
  • Belgium · Omniscan
  • Bulgaria · Омнискен
  • Cyprus · Omniscan
  • Germany · Omniscan
  • Estonia · Omniscan
  • United Kingdom (Northern Ireland) · Omniscan
  • Greece · Omniscan
  • Croatia · Omniscan
  • Hungary · Omniscan
  • Ireland · Omniscan
  • Iceland · Omniscan
  • Italy · Omniscan
  • Lithuania · Omniscan
  • Luxembourg · Omniscan
  • Latvia · Omniscan
  • Malta · Omniscan
  • Netherlands · Omniscan
  • Norway · Omniscan
  • Poland · Omniscan
  • Portugal · Omniscan
  • Romania · Omniscan
  • Sweden · Omniscan
  • Slovenia · Omniscan
  • Slovakia · Omniscan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af0f6eab-9c7d-4b27-b0e1-b82e1588f237
GET /v1/drugs/af0f6eab-9c7d-4b27-b0e1-b82e1588f237?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario Y Centros De Diagnóstico Autorizados",
  "estado": "{\"aut\":930780000000,\"rev\":1663932857000}",
  "nregistro": "62699",
  "substance": "gadodiamida"
}

See everything about gadodiamida.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.